Back to top

Athersys (ATHX) in Focus: Stock Moves 10.22% Higher
September 07, 2017

Read MoreHide Full Article

Athersys, Inc.(ATHX - Free Report) was a big mover last session, as the company saw its shares rise more than 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 31.4% in the past one-month time frame

The company has not seen any estimate revision change over the past few weeks, while the Zacks Consensus Estimate for the current quarter has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Athersys currently has a Zacks Rank 2 (Buy) while its Earnings ESP is 0.00%.

Another stock worth considering in the Medical sector is Akari Therapeutics, Plc (AKTX - Free Report) which carries a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ATHX going up? Or down? Predict to see what others think: Up or Down

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.

Learn more >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Athersys, Inc. (ATHX) - free report >>

Akari Therapeutics PLC (AKTX) - free report >>


More from Zacks Tale of the Tape

You May Like